Virus Filtration Market Segmentation by Product (Filtration Systems, Kits & Reagents, and Services); by Application (Medical Devices, Water Purification, Air Purification, and Biologicals); by End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Academic Research Institutes, Medical Device Companies, and Others)-Global Demand Analysis & Opportunity Outlook 2031
-
Product Code:
RP-ID-10070474 -
Published Date:
21 Oct 2022 -
Region:
Global
-
Category:
Healthcare & Pharmaceuticals -
Publisher:
Pub-ID-54
Impact Analysis on the Growth of Market
Inflation and Looming Recession to Haunt Businesses:
In 2022 & 2023, market players expected to sail in rough waters; might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain. Further, U.S. economy is expected to grow merely by 3% in 2022.
....
The Research Report is Updated with 2022 Base Year, 2023 Estimated year and Forecast till 2035 with Market Insights.
With the dip in global production, the GDP has contracted in 2020 and impacted the market across the world. Upon placing a Sample Request, you will receive an updated report with 2022 as base year, 2023 as estimated year and forecast to 2035. This will have market drivers, recovery rate in the market, insights and competitive analysis.
Market Overview:
Translate Report
Global Virus Filtration Market Highlights Over 2022 - 2031
The global virus filtration market is estimated to garner around USD 7 billion in revenue by 2031 by growing at a CAGR of nearly 13% over the forecast period, i.e., 2022 – 2031. The growth of the market can be attributed to increasing number of chronic diseases, including cancer, diabetes, and autoimmune disorders. According to a report by the World Health Organization (WHO), the estimated number of deaths due to cancer was nearly 10 million in 2020, which was approximately one in six deaths.
CLICK TO DOWNLOAD A SAMPLE REPORT
Additionally, the rapid growth in the R&D sector, increasing fund availability in the biopharmaceutical sector, and increasing government support are the factors that are also propelling the growth of the global virus filtration market. The COVID-19 pandemic had a positive impact on the virus filtration market owing to the several clinical trials related to virus filtration aiming to find strategies for infection prevention, especially to prevent community spread.
However, stringent rules and regulations regarding the filtration of products, and intense competition among vendors are the key factors restraining the growth of the market.
The market is segmented by product into filtration systems, kits & reagents, and services, out of which, the kits & reagents segment is anticipated to hold the major share over the forecast period. The growth can be attributed to increasing demand for these products in everyday laboratory use. The reagents support in decreasing the potential of iatrogenic transmission of pathogenic viruses, which is driving their demand.
Global Virus Filtration Market Regional Synopsis
Regionally, the global virus filtration market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America, and Middle East & Africa region. The market in North America region is estimated to witness significant growth over the forecast period on the back of the increasing incidence of diseases, and the high presence of pharmaceutical companies in the region. Moreover, there has been an increasing number of incidents related to adventitious viruses in the manufacturing processes which increased regulatory scrutiny, and R&D activities by biopharmaceutical companies. These factors are also expected to drive the market growth in the region.
Asia Pacific region is expected to witness market growth at the highest CAGR during the forecast period on the back of increasing government initiatives for industrialization, increasing presence of clinical research organizations (CROs) that helps in R&D activities, availability of labor at low cost, and comparatively less stringent regulatory policies. These factors are also expected to provide lucrative opportunities for market players to invest in the region.
Market Segmentation
Our in-depth analysis of the global virus filtration market includes the following segments:
By Product
-
Filtration Systems
-
Kits & Reagents
-
Services
By Application
-
Medical Devices
-
Water Purification
-
Air Purification
-
Biologicals
By End-User
-
Pharmaceutical and Biotechnology Companies
-
Contract Research Organizations
-
Academic Research Institutes
-
Medical Device Companies
-
Others
Growth Drivers and Challenges Impacting the Growth of the Global Virus Filtration Market
Growth Drivers
-
Increasing number of chronic diseases, including cancer, diabetes, and autoimmune disorders
-
Rapid growth in the R&D sector, and increasing fund availability in the biopharmaceutical sector
Challenges
-
Stringent rules and regulations regarding the filtration of products
-
Intense competition among vendors
Key Companies Dominating the Global Virus Filtration Market
Our report has covered detailed company profiling comprising company overview, business strategies, key product offerings, financial performance, key performance indicators, risk analysis, recent developments, regional presence, and SWOT analysis among other notable indicators for competitive positioning. Some of the prominent industry leaders in the global virus filtration market that are included in our report are Thermo Fisher Scientific Inc., Merck KGaA, Sartorius AG, WuXi AppTec, Charles River Laboratories, Asahi Kasei Corporation, Lonza, Pall Corporation, General Electric, Danaher, Pfizer Inc., GlaxoSmithKline plc, and others.
Latest Developments in the Global Virus Filtration Market:
-
September 2019: Asahi Kasei Corporation accomplished a new plant in Nobeoka, Miyazaki, Japan for the spinning of cellulose hollow-fiber membranes for Planova virus removal filters.
-
February 2018: Merck KGa launched Viresolve Barrier capsule filters to reduce the risk of bioreactor contamination, as they are designed to remove viruses, mycoplasma and bacteria from cell culture media.
Key Reasons to Buy Our Report
-
The report covers detailed analysis comprising market share attained by each market segment and its sub-segments.
-
It covers market dynamics including growth drivers, trends, potential opportunities, price trend analysis and challenges that impact the market growth.
-
The report includes detailed company profiles of the major players dominating the market.
-
We use effective research methodologies to calculate the market numbers and provide value-added assessment for overall growth.
-
We provide customized reports as per the clients’ requirement helping them to see possible and unexpected challenges and unforeseen opportunities in order to help them reach their goal.
Geography Analysis:
The report further discusses the market opportunity, compound annual growth rate (CAGR) growth rate, competition, new technology innovations, market players analysis, government guidelines, export and import (EXIM) analysis, historical revenues, future forecasts etc. in the following regions and/or countries:
- North America (U.S. & Canada) Market Size, Y-O-Y Growth, Market Players Analysis & Opportunity Outlook
- Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
- Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC(Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market Size, Y-O-Y Growth Market Players Analys & Opportunity Outlook
- Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
- Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market Size, Y-O-Y Growth Market Players Analysis & Opportunity Outlook
.
FREQUENTLY ASKED QUESTIONS
Increasing number of chronic diseases, including cancer, diabetes, and autoimmune disorders, rapid growth in the R&D sector, and increasing fund availability in the biopharmaceutical sector are the major factors driving the growth of the market.
The market is anticipated to attain a CAGR of ~13% over the forecast period, i.e., 2022-2031.
Stringent rules and regulations regarding the filtration of products, and intense competition among vendors are estimated to hamper the market growth.
Asia Pacific region is anticipated to provide more business opportunities over the forecast period for the growth of the market.
The major players in the market are Thermo Fisher Scientific Inc., Merck KGaA, Sartorius AG, WuXi AppTec, Charles River Laboratories, Asahi Kasei Corporation, Lonza, Pall Corporation, General Electric, Danaher, Pfizer Inc., GlaxoSmithKline plc, and others.
The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.
The market is segmented by product, application, end user, and by region.
The kits & reagents segment is anticipated to hold largest market size in value and display significant growth opportunities.
Please enter your personal details below
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Sartorius AG
- WuXi AppTec
- Charles River Laboratories
- Asahi Kasei Corporation
- Lonza
- Pall Corporation
- General Electric
- Danaher
- Pfizer Inc.
- GlaxoSmithKline plc